KPRXKIORA PHARMACEUTICALS INC

Nasdaq kiorapharma.com


$ 0.49 $ 0.00 (0.19 %)    

Friday, 10-May-2024 15:15:06 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 0.4862
$ 0.50
$ 0.00 x 0
$ 0.50 x 100
$ 0.49 - $ 0.50
$ 0.45 - $ 2.65
227,225
na
17.03M
$ 0.80
$ 6.06
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 07-08-2022 03-31-2022 10-Q
10 04-15-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-04-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-01-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-11-2018 03-31-2018 10-Q
26 03-02-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-01-2016 09-30-2016 10-Q
32 08-10-2016 06-30-2016 10-Q
33 05-13-2016 03-31-2016 10-Q
34 03-30-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-15-2015 03-31-2015 10-Q
38 03-31-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 kiora-pharmaceuticals-to-present-additional-data-from-its-abacus-1-trial-of-kio-301-in-retinitis-pigmentosa-at-arvo-2024-annual-meeting

https://www.newsfilecorp.com/release/203326

 hc-wainwright--co-maintains-buy-on-kiora-pharmaceuticals-maintains-2-price-target

HC Wainwright & Co. analyst Yi Chen maintains Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $2 price target.

 hc-wainwright--co-maintains-buy-on-kiora-pharmaceuticals-adjusts-price-target-to-2

HC Wainwright & Co. analyst Yi Chen maintains Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy, adjusts target to $2 from ...

 why-skechers-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarte...

 why-meta-shares-are-trading-higher-by-over-16-here-are-20-stocks-moving-premarket

Shares of Meta Platforms, Inc. (NASDAQ: META) rose sharply in today’s pre-market trading as the company reported upbeat fourth-...

 why-ch-robinson-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-...

 whats-going-on-with-kiora-pharmaceuticals-stock

Kiora Pharmaceuticals also entered into a securities purchase agreement with certain institutional investors, pursuant to which...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION